You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

CLINICAL TRIALS PROFILE FOR AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02292069 ↗ Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fed Condition Completed Dr. Reddy's Laboratories Limited Phase 1 2011-09-01 This study is to assess the bioequivalence between Amlodipine besylate/Atorvastatin calcium Tablets 10mg/80mg of Dr. Reddy's Laboratories Limited, India and CADUET® (amlodipine besylate and atorvastatin calcium) tablets 10mg/80mg of Pfizer Ireland Pharmaceuticals Dublin, Ireland in healthy, adult,human subjects under Fed conditions.
NCT02295046 ↗ Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fasting Condition Completed Dr. Reddy's Laboratories Limited Phase 1 2011-10-01 This study is to assess the bioequivalence between Amlodipine besylate/Atorvastatin calcium Tablets 10mg/80mg of Dr. Reddy's Laboratories Limited, India and CADUET® (amlodipine besylate and atorvastatin calcium) tablets 10mg/80mg of Pfizer Ireland Pharmaceuticals Dublin, Ireland in Healthy Male and Female Volunteers under Fasting conditions.
NCT03299452 ↗ Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor Unknown status Alphacait, LLC Phase 2 2017-01-01 This is a single-center, open-label, single-arm, non-randomized study designed to evaluate PFS, safety, overall survival (OS), objective response rate (OPR), disease control rate (DCR) and biomarkers of cancer therapy based on Alphacait screening system in subjects with advanced malignant tumor.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM

Condition Name

Condition Name for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
Intervention Trials
Healthy 2
Metastatic Cancer 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
Intervention Trials
Neoplasm Metastasis 1
Malnutrition 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM

Trials by Country

Trials by Country for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
Location Trials
Germany 1
India 1
China 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM

Clinical Trial Phase

Clinical Trial Phase for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
Clinical Trial Phase Trials
Phase 2 1
Phase 1 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
Clinical Trial Phase Trials
Completed 2
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM

Sponsor Name

Sponsor Name for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
Sponsor Trials
Dr. Reddy's Laboratories Limited 2
Alphacait, LLC 1
Haining Health-Coming Biotech Co., Ltd. 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
Sponsor Trials
Industry 2
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.